155 related articles for article (PubMed ID: 16094092)
21. Hemolysis from ceftriaxone.
Med Lett Drugs Ther; 2002 Nov; 44(1144):100-1. PubMed ID: 12451362
[No Abstract] [Full Text] [Related]
22. Ceftriaxone-induced biliary pseudolithiasis and urinary bladder sludge.
Acun C; Erdem LO; Sogut A; Erdem CZ; Tomac N; Gundogdu S
Pediatr Int; 2004 Jun; 46(3):368-70. PubMed ID: 15151561
[No Abstract] [Full Text] [Related]
23. Are we finally ready for outpatient management of febrile neutropenia?
Saini S; Rosoff PM
Pediatr Blood Cancer; 2007 Nov; 49(6):765-6. PubMed ID: 17514730
[No Abstract] [Full Text] [Related]
24. A report of near fatal ceftriaxone induced anaphylaxis in a child with review of literature.
Shrestha D; Dhakal AK; Shakya H; Shah SC; Shakya A
Nepal Med Coll J; 2013 Mar; 15(1):84-6. PubMed ID: 24592804
[TBL] [Abstract][Full Text] [Related]
25. [Ceftriaxone: whether there is future for it?].
Sidorenko SV
Antibiot Khimioter; 2006; 51(8):3-9. PubMed ID: 18030778
[No Abstract] [Full Text] [Related]
26. [Drug-induced calculi].
Hammann C; Guelpa G
Schweiz Rundsch Med Prax; 1993 Oct; 82(41):1129-32. PubMed ID: 8210886
[TBL] [Abstract][Full Text] [Related]
27. Severe hemolytic crisis after ceftriaxone administration.
Goyal M; Donoghue A; Schwab S; Hasbrouck N; Khojasteh S; Osterhoudt K
Pediatr Emerg Care; 2011 Apr; 27(4):322-3. PubMed ID: 21467885
[TBL] [Abstract][Full Text] [Related]
28. Treatment of pediatric bacterial meningitis with a 7-day regimen of once-daily ceftriaxone injections. Multicentre study carried out in non-university pediatric departments in the French and Italian-speaking regions of Switzerland.
Renevey F; Martin E; Fröscher F; Reusser P
J Chemother; 1989 Jul; 1(4 Suppl):678-9. PubMed ID: 16312589
[No Abstract] [Full Text] [Related]
29. [Cholelithiasis associated with the use of ceftriaxone].
Costa DL; Barbosa MD; Barbosa MT
Rev Soc Bras Med Trop; 2005; 38(6):521-3. PubMed ID: 16410930
[TBL] [Abstract][Full Text] [Related]
30. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
Metallidis S; Kollaras P; Giannakakis T; Seitanidis B; Kordosis T; Nikolaidis J; Hatzitolios A; Nikolaidis P
Eur J Intern Med; 2008 Dec; 19(8):619-24. PubMed ID: 19046729
[TBL] [Abstract][Full Text] [Related]
31. Drug-induced liver injury associated with high-dose ceftriaxone: a retrospective cohort study adjusted for the propensity score.
Nakaharai K; Sakamoto Y; Yaita K; Yoshimura Y; Igarashi S; Tachikawa N
Eur J Clin Pharmacol; 2016 Aug; 72(8):1003-11. PubMed ID: 27126206
[TBL] [Abstract][Full Text] [Related]
32. Comment: Clinical pharmaceutics and calcium ceftriaxone.
Puzovic M; Hardy G
Ann Pharmacother; 2008 Dec; 42(12):1914. PubMed ID: 19033487
[No Abstract] [Full Text] [Related]
33. Intravascular haemolysis in a patient on ceftriaxone with demonstration of anticeftriaxone antibodies.
Dinesh D; Dugan N; Carter J
Intern Med J; 2008 Jun; 38(6):438-41. PubMed ID: 18613898
[TBL] [Abstract][Full Text] [Related]
34. Ceftriaxone-associated biliary pseudolithiasis.
Rienstra M; Bonten MJ; Gaillard CA
Neth J Med; 2009 Mar; 67(3):113-4. PubMed ID: 19307687
[No Abstract] [Full Text] [Related]
35. Moxifloxacin is non-inferior to combination therapy with ceftriaxone plus metronidazole in patients with community-origin complicated intra-abdominal infections.
Solomkin J; Zhao YP; Ma EL; Chen MJ; Hampel B;
Int J Antimicrob Agents; 2009 Nov; 34(5):439-45. PubMed ID: 19692210
[TBL] [Abstract][Full Text] [Related]
36. Acute interstitial nephritis associated with coadministration of vancomycin and ceftriaxone: case series and review of the literature.
Plakogiannis R; Nogid A
Pharmacotherapy; 2007 Oct; 27(10):1456-61. PubMed ID: 17896901
[TBL] [Abstract][Full Text] [Related]
37. Ceftriaxone-induced Neurotoxicity in a Patient after Pancreas-Kidney Transplantation.
Hagiya H; Miyawaki K; Yamamoto N; Yoshida H; Kitagawa A; Asaoka T; Eguchi H; Akeda Y; Tomono K
Intern Med; 2017 Nov; 56(22):3103-3107. PubMed ID: 28943562
[TBL] [Abstract][Full Text] [Related]
38. [Reimbursement policy for ambulatory treatment of pediatric infections with ceftriaxone].
Krahenbuhl JD; Di Paolo E; Steiner S; Gehri M
Rev Med Suisse; 2005 Jul; 1(27):1814-5. PubMed ID: 16119297
[No Abstract] [Full Text] [Related]
39. [Ceftriaxone-induced thrombocytopenia].
López-Gómez M; Arrebola Nacle JP; López-Ruz MA; Jiménez-Alonso J
Rev Clin Esp; 2004 Aug; 204(8):441-2. PubMed ID: 15274775
[No Abstract] [Full Text] [Related]
40. DRESS like severe drug rash with eosinophilia, atypic lymphocytosis and fever secondary to ceftriaxone.
Akcam FZ; Aygun FO; Akkaya VB
J Infect; 2006 Aug; 53(2):e51-3. PubMed ID: 16352341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
